CSD500 Update

RNS Number : 6119J

Futura Medical PLC

08 August 2012

 



For immediate release 8 August 2012

Futura Medical plc

("Futura" or "the Company")

CSD500 UPDATE

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, confirms that it is in negotiations with Reckitt Benckiser regarding the parties' options in relation to the global licence agreement for CSD500.

The outcome of these negotiations is uncertain. Futura expects to update the market shortly.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.com
Nomura Code Securities Limited
Phil Walker / Giles Balleny	Tel:[phone]
For media enquiries please contact:
Buchanan
Mark Court / Fiona Henson / Sophie Cowles	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.com

 

END

 

 

MSCUWVORUNAWRAR